Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.44)
# 2,495
Out of 5,050 analysts
131
Total ratings
51.9%
Success rate
-1.98%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $23.43 | +28.04% | 5 | Nov 7, 2025 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $28 | $20.31 | +37.86% | 1 | Nov 7, 2025 | |
| DOCS Doximity | Maintains: Outperform | $81 → $70 | $54.29 | +28.94% | 10 | Nov 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $83 → $90 | $71.90 | +25.17% | 2 | Nov 5, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $190 → $220 | $203.67 | +8.02% | 10 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: In-Line | $9 → $8 | $7.53 | +6.24% | 6 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Outperform | $85 → $95 | $78.99 | +20.27% | 7 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $160 → $170 | $134.84 | +26.08% | 15 | Oct 30, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $17 → $13 | $11.18 | +16.28% | 8 | Oct 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $220 → $240 | $210.46 | +14.04% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $44.49 | +46.10% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $2.83 | +6.01% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $7 → $11 | $11.25 | -2.22% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $190 | $179.50 | +5.85% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $252.72 | +20.69% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $851.99 | -3.17% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $19.45 | +18.25% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.67 | +349.64% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $36 | $36.22 | -0.61% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $3.39 | +674.34% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $4.08 | +267.65% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $1.73 | +535.84% | 2 | Jan 4, 2022 |
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $23.43
Upside: +28.04%
Omada Health
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $20.31
Upside: +37.86%
Doximity
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $54.29
Upside: +28.94%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $83 → $90
Current: $71.90
Upside: +25.17%
Cardinal Health
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $203.67
Upside: +8.02%
Teladoc Health
Oct 30, 2025
Maintains: In-Line
Price Target: $9 → $8
Current: $7.53
Upside: +6.24%
CVS Health
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $78.99
Upside: +20.27%
Align Technology
Oct 30, 2025
Maintains: Outperform
Price Target: $160 → $170
Current: $134.84
Upside: +26.08%
DENTSPLY SIRONA
Oct 8, 2025
Maintains: In-Line
Price Target: $17 → $13
Current: $11.18
Upside: +16.28%
IQVIA Holdings
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $210.46
Upside: +14.04%
Oct 8, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $44.49
Upside: +46.10%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $2.83
Upside: +6.01%
Oct 8, 2025
Maintains: In-Line
Price Target: $7 → $11
Current: $11.25
Upside: -2.22%
Oct 8, 2025
Maintains: In-Line
Price Target: $185 → $190
Current: $179.50
Upside: +5.85%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $252.72
Upside: +20.69%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $851.99
Upside: -3.17%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $19.45
Upside: +18.25%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.67
Upside: +349.64%
Nov 7, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $36.22
Upside: -0.61%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $3.39
Upside: +674.34%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.08
Upside: +267.65%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.73
Upside: +535.84%